Insulet price target raised to $300 from $270 at BTIG
BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology ...
FTAI Aviation price target raised to $190 from $180 at BTIG
BTIG analyst Andre Madrid raised the firm’s price target on FTAI Aviation (FTAI) to $190 from $180 and keeps a Buy rating on the shares. The ...
Boston Scientific price target raised to $101 from $97 at BTIG
BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating ...
Verastem price target raised to $20 from $13 at BTIG
BTIG raised the firm’s price target on Verastem (VSTM) to $20 from $13 and keeps a Buy rating on the shares after the company announced the FDA ...